Seasoned investor and operating executive focused on growth-stage technology and financial-services businesses. Chris Kleine brings experience directing capital allocation, portfolio transformation, and strategic M&A while serving on boards and leading commercial scaling initiatives. He blends investment sourcing, due diligence, and hands-on operational improvement to drive EBITDA expansion and exit planning. Prior roles span investment management and senior operating functions; holds advanced business credentials and is active in deal syndication and limited partner networks. Market-relevant expertise includes growth equity, operational turnarounds, and governance oversight.
Seasoned investor and operating executive focused on growth-stage technology and financial-services businesses. Chris Kleine brings experience directing capital allocation, portfolio transformation, and strategic M&A while serving on boards and leading commercial scaling initiatives. He blends investment sourcing, due diligence, and hands-on operational improvement to drive EBITDA expansion and exit planning. Prior roles span investment management and senior operating functions; holds advanced business credentials and is active in deal syndication and limited partner networks. Market-relevant expertise includes growth equity, operational turnarounds, and governance oversight.
Focuses on growth-stage technology and financial-services companies, pursuing concentrated growth-equity investments where operational intervention accelerates value creation. Prioritizes rigorous due diligence, board-level governance, and disciplined capital allocation to catalyze EBITDA expansion through commercial scaling, margin improvement, and targeted M&A. Favors multi-year hold periods that balance active operational involvement with exit-driven value realization. Risk-managed portfolio construction combines selective syndication with hands-on turnaround playbooks, emphasizing scalable revenue models, repeatable unit economics, and clear governance milestones to de-risk exits.
Focuses on growth-stage technology and financial-services companies, pursuing concentrated growth-equity investments where operational intervention accelerates value creation. Prioritizes rigorous due diligence, board-level governance, and disciplined capital allocation to catalyze EBITDA expansion through commercial scaling, margin improvement, and targeted M&A. Favors multi-year hold periods that balance active operational involvement with exit-driven value realization. Risk-managed portfolio construction combines selective syndication with hands-on turnaround playbooks, emphasizing scalable revenue models, repeatable unit economics, and clear governance milestones to de-risk exits.
| Trades 758 | Longs Won 443/758 58% | Profit Factor 1.63 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $244,035.67 |
| Average Win $72,694.7 | Best Trade (Oct 14) $4.98M | Sharpe Ratio -9.61 |
| Average Loss -$62,564.53 | Worst Trade (Oct 16) -$1.47M | Z-Score -1.02 (69.47%) |
| Commissions $0 | Avg. Trade Length 7m 1w 2d | Expectancy $16,565.57 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 3,086 | 2,778 | 2,469 | 2,160 | 1,852 | 1,543 | 1,235 | 926 | 617 | 309 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 24,711 | $6.23M | $8.52M | - | $2.29M | 36.66% | +0.81% |
AAT American Assets Trust, Inc. | 15,602 | $331,699 | $333,414.74 | - | $1,715.74 | 0.52% | -0.373% |
ABBV AbbVie Inc. | 971 | $226,772.2 | $276,380.58 | - | $49,608.38 | 21.88% | +0.436% |
ABEV Ambev S.A. | 19,653 | $57,386.95 | $64,167.04 | - | $6,780.09 | 11.81% | +0.153% |
ACHR Archer Aviation Inc. | 29,284 | $145,541 | $119,771.56 | - | -$25,769.44 | -17.71% | -4.215% |
ADAM Adamas Trust, Inc. | 14,010 | $125,847.42 | $108,321.12 | - | -$17,526.3 | -13.93% | -0.748% |
ADI Analog Devices, Inc. | 613 | $243,230 | $250,180.62 | - | $6,950.62 | 2.86% | +1.034% |
ADT ADT Inc. | 43,802 | $266,316 | $302,233.8 | - | $35,917.8 | 13.49% | +0.583% |
AHRT AMERICAN HEALTHCARE REIT INC | 31,574 | $189,325.95 | $190,391.22 | - | $1,065.27 | 0.56% | +1.005% |
ALAB ASTERA LABS INC COMMON STOCK (Ticker: 1ALAB) | 4,353 | $1.55M | $1.26M | - | -$285,587.8 | -18.43% | -3.835% |
AMAT Applied Materials, Inc. | 684 | $494,571.3 | $285,275.88 | - | -$209,295.42 | -42.32% | -3.009% |
AMCX AMC Networks Inc. | 18,057 | $180,208.6 | $187,973.37 | - | $7,764.77 | 4.31% | -3.789% |
AMD Advanced Micro Devices, Inc. | 4,337 | $2.52M | $2.35M | - | -$166,735.92 | -6.62% | -3.515% |
AMGN Amgen Inc. | 950 | $264,741.58 | $413,022 | - | $148,280.42 | 56.01% | +0.168% |
AMSC American Superconductor Corporation | 8,208 | $238,935 | $216,362.88 | - | -$22,572.12 | -9.45% | -1.971% |
AMZN Amazon.com Inc | 5,152 | $1.13M | $1.3M | - | $169,425.31 | 14.93% | -0.62% |
ANET Arista Networks, Inc. | 3,620 | $527,470.23 | $651,419 | - | $123,948.77 | 23.5% | -3.034% |
AOS A. O. Smith Corporation | 6,659 | $375,355 | $397,309.23 | - | $21,954.23 | 5.85% | +0.328% |
ASML ASML Holding N.V. New York Registry Shares | 173 | $342,928.69 | $288,660.88 | - | -$54,267.81 | -15.82% | +0.671% |
ASX ASE Technology Holding Co., Ltd. Sponsored ADR | 5,987 | $269,646.48 | $241,306.03 | - | -$28,340.45 | -10.51% | -3.784% |